The most common alteration seen in pancreatic cancer include KRAS protooncogene (KRAS) gene, which regulates the transforming growth factor beta (TGF-β), Notch, and Wnt signaling pathways have been extensively studied in pancreatic cancer [13]. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.